Skip to main content
AAO-HNSF 2024 Annual Meeting & OTO EXPO Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Panel Presentations

Facial Plastic and Reconstructive Surgery

Navigating Trends and Risks: Delving Into Complications of Injectable Neuromodulators and Fillers

Sunday, September 29, 2024
4:00 PM – 5:00 PM EDT
Location: MBCC, 232
CME/MOC Credit: 1
Disclosure(s):
Anas A. Eid, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Leslie R. Kim, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Scott R. Owen, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

PROGRAM DESCRIPTION: This expert panel aims to illuminate the intricate landscape of complications arising from the use of neuromodulators and fillers, specifically tailored for otolaryngologists. The program will conduct a comprehensive examination of the complication spectrum, encompassing both common and uncommon issues. Practical insights will be shared regarding consent and patient education, alongside effective risk mitigation and management strategies. The panelists, recognized experts in the field, will actively engage in discussions to elevate the audience's understanding and proficiency in effectively handling complications.

This panel aims to meet the growing need for insights into the complexities associated with both rare and common complications, serving as a platform for experts to share knowledge, exchange experiences, and contribute to ongoing improvements in patient safety and outcomes in the use of botulim toxins and fillers.

Learning Objectives:

  1. Exploring the Complication Spectrum: Investigate the diverse range of complications associated with the use of neuromodulators and fillers in facial plastic surgery, covering mild to severe, common to uncommon issues, and understand their underlying causes.
  2. Enhance Risk Mitigation Strategies: Discuss and share effective strategies for mitigating risks linked to neuromodulator and filler applications, with a focus on prevention, early recognition, and comprehensive management of complications.
  3. Optimize Patient Outcomes: Provide insights and recommendations for optimizing patient outcomes by addressing complications promptly, understanding modifiable risk factors, ensuring patient safety, and fostering a collaborative approach among practitioners.

    Moderator(s)

  • Anas A. Eid, MD

    Division Director, Assistant Professor in Facial Plastic & Reconstructive Microsurgery
    University of Tennessee
    memphis, TN, United States

    Disclosure(s):

    faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

    • Panelist(s)

  • Leslie R. Kim, MD

    Clinical Associate Professor and Director of Facial Plastic Surgery
    The Ohio State University Wexner Medical Center
    Columbus, OH, United States

    Disclosure(s):

    faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

  • Scott R. Owen, MD

    Dir. Facial Plastic and Reconstructive Surgery
    University of Iowa
    Iowa City, IA, United States

    Disclosure(s):

    faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

  • Linda N. Lee, MD

    Facial Plastic & Reconstructive Surgery
    Harvard Medical School / Massachusetts Eye and Ear Infirmary
    Boston, MA, United States

    Disclosure information not submitted.